Organization
Shanghai Key Laboratory of Maternal Fetal Medicine Shanghai
2 abstracts
Abstract
Effect of cancer immunotherapy with CD39/PD-L1 bispecific antibody OriA631-b.Org: Shanghai Key Laboratory of Maternal Fetal Medicine Shanghai, Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital Affiliated with Jinan University,
Abstract
Enhanced anti-ovarian cancer efficacy with MSLN-chimeric antigen receptor T cells secreting anti-CD39 antibody.Org: OriCell Therapeutics, Shanghai Key Laboratory of Maternal Fetal Medicine Shanghai, Institute of Maternal-Fetal Medicine and Gynecologic Oncology,